 Kami Schneider
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Counseling | 5 | 2021 | 65 | 1.080 |
Why?
| | Neurofibromatosis 1 | 2 | 2021 | 36 | 0.850 |
Why?
| | Anemia, Aplastic | 1 | 2021 | 30 | 0.750 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.730 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 18 | 0.730 |
Why?
| | Codon, Nonsense | 1 | 2020 | 37 | 0.720 |
Why?
| | Eye Proteins | 1 | 2020 | 70 | 0.710 |
Why?
| | Myelodysplastic Syndromes | 1 | 2021 | 119 | 0.690 |
Why?
| | Kidney Neoplasms | 2 | 2021 | 327 | 0.680 |
Why?
| | Wilms Tumor | 1 | 2020 | 68 | 0.680 |
Why?
| | Genetic Testing | 3 | 2021 | 379 | 0.670 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2021 | 534 | 0.520 |
Why?
| | Ribonuclease III | 3 | 2021 | 34 | 0.490 |
Why?
| | DEAD-box RNA Helicases | 3 | 2021 | 56 | 0.480 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1040 | 0.470 |
Why?
| | Phenotype | 1 | 2021 | 2796 | 0.420 |
Why?
| | Neoplastic Syndromes, Hereditary | 3 | 2022 | 30 | 0.420 |
Why?
| | Mutation | 2 | 2021 | 3346 | 0.370 |
Why?
| | Central Nervous System Neoplasms | 2 | 2023 | 126 | 0.320 |
Why?
| | Fellowships and Scholarships | 1 | 2011 | 227 | 0.310 |
Why?
| | Societies, Medical | 1 | 2011 | 663 | 0.290 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 615 | 0.250 |
Why?
| | Students | 1 | 2009 | 502 | 0.240 |
Why?
| | Prognosis | 3 | 2021 | 3329 | 0.240 |
Why?
| | DNA Mismatch Repair | 2 | 2022 | 37 | 0.240 |
Why?
| | Brain Neoplasms | 2 | 2022 | 979 | 0.230 |
Why?
| | Germ-Line Mutation | 2 | 2021 | 130 | 0.210 |
Why?
| | Child, Preschool | 5 | 2021 | 9114 | 0.190 |
Why?
| | DNA Repair Enzymes | 1 | 2021 | 22 | 0.190 |
Why?
| | Pulmonary Blastoma | 1 | 2021 | 8 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 12 | 0.180 |
Why?
| | Early Detection of Cancer | 2 | 2021 | 328 | 0.170 |
Why?
| | Child | 8 | 2023 | 18412 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 4 | 2021 | 2086 | 0.150 |
Why?
| | Codes of Ethics | 1 | 2017 | 16 | 0.150 |
Why?
| | Ethics, Professional | 1 | 2017 | 14 | 0.150 |
Why?
| | Counselors | 1 | 2017 | 11 | 0.150 |
Why?
| | Retinoblastoma Binding Proteins | 1 | 2017 | 3 | 0.150 |
Why?
| | Optic Nerve Glioma | 1 | 2017 | 1 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2023 | 3003 | 0.140 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2017 | 8 | 0.140 |
Why?
| | Neurofibromatoses | 1 | 2017 | 6 | 0.140 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 12 | 0.140 |
Why?
| | Pinealoma | 1 | 2017 | 11 | 0.140 |
Why?
| | Neurilemmoma | 1 | 2017 | 19 | 0.140 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2017 | 31 | 0.140 |
Why?
| | Neoplasms | 2 | 2021 | 2097 | 0.140 |
Why?
| | Retinoblastoma | 1 | 2017 | 26 | 0.140 |
Why?
| | Humans | 17 | 2023 | 114674 | 0.140 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2017 | 59 | 0.140 |
Why?
| | Neuroblastoma | 1 | 2017 | 133 | 0.130 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 139 | 0.130 |
Why?
| | Genetic Association Studies | 1 | 2018 | 339 | 0.130 |
Why?
| | Infant | 4 | 2023 | 7961 | 0.130 |
Why?
| | Follow-Up Studies | 2 | 2021 | 4411 | 0.120 |
Why?
| | Adolescent | 5 | 2023 | 17841 | 0.110 |
Why?
| | Male | 6 | 2021 | 55589 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2017 | 756 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2177 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2023 | 12549 | 0.080 |
Why?
| | Universities | 1 | 2009 | 340 | 0.070 |
Why?
| | Female | 5 | 2021 | 59499 | 0.060 |
Why?
| | United States | 3 | 2021 | 12182 | 0.060 |
Why?
| | Microsatellite Instability | 1 | 2022 | 32 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 57 | 0.050 |
Why?
| | Microsatellite Repeats | 1 | 2022 | 136 | 0.050 |
Why?
| | Cause of Death | 1 | 2023 | 361 | 0.050 |
Why?
| | Prospective Studies | 2 | 2023 | 6219 | 0.050 |
Why?
| | Kidney Diseases, Cystic | 1 | 2021 | 21 | 0.050 |
Why?
| | Pneumothorax | 1 | 2021 | 42 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 333 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2021 | 274 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 460 | 0.040 |
Why?
| | Protein Domains | 1 | 2021 | 207 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4408 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2020 | 182 | 0.040 |
Why?
| | Adult | 3 | 2021 | 30546 | 0.040 |
Why?
| | Population Surveillance | 1 | 2021 | 392 | 0.040 |
Why?
| | Penetrance | 1 | 2018 | 27 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 635 | 0.040 |
Why?
| | Inheritance Patterns | 1 | 2018 | 45 | 0.040 |
Why?
| | Counseling | 1 | 2020 | 342 | 0.040 |
Why?
| | Societies | 1 | 2017 | 38 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2018 | 61 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1644 | 0.030 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 167 | 0.030 |
Why?
| | Global Health | 1 | 2018 | 287 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 226 | 0.030 |
Why?
| | Neuroimaging | 1 | 2017 | 249 | 0.030 |
Why?
| | Disease Management | 1 | 2018 | 560 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 463 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 573 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1760 | 0.030 |
Why?
| | Parents | 1 | 2020 | 1186 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2251 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2285 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1004 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1468 | 0.020 |
Why?
| | Pediatrics | 1 | 2017 | 979 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1528 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 2968 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3046 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10466 | 0.020 |
Why?
|
|
Schneider's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|